Limfom grlića materice – retka klinička prezentacija

  • Dušica Petrović Rodić University of Kragujevac, Faculty of Medical Sciences, Department of Pathology, Kragujevac, Serbia
  • Tatjana Kastratović University Medical Center Kragujevac, Department of Gynecology and Obstetrics, Kragujevac, Serbia
  • Danijela Jovanović University of Kragujevac, Faculty of Medical Sciences, Department of Internal Medicine, Kragujevac, Serbia
  • Vladan Marković University of Kragujevac, Faculty of Medical Sciences, Department of Radiology, Kragujevac, Serbia
  • Jasmina Stojanović University of Kragujevac, Faculty of Medical Sciences, Department of Otorhinolaryngology, Kragujevac, Serbia
  • Dalibor Jovanović University of Kragujevac, Faculty of Medical Sciences, Department of Pathology, Kragujevac, Serbia
Ključne reči: biopsija, limfom, nehodžkinov, papillomaviridae, serotipizacija, grlić materice, displazija

Sažetak


Uvod. Limfomi su maligne bolesti limfocitne loze. Postoje dva osnovna tipa limfoma: Hodgkin-ov limfom (HL), čija je osnovna karakteristika prisustvo Reed-Sternberg-ovih ćelija, i non-Hodgkin-ov limfom (NHL), koji predstavlja heterogenu grupu bolesti, a u zavisnosti od brzine rasta i toka bolesti mogu biti indolentni (spororastući tok) i agresivni (brzorastući tok). Folikularni limfom (FL) najčešći je indolentni oblik NHL, dok je difuzni krupnoćelijski B‑limfom (diffuse large b-cell lymphoma, DLBCL) najčešći agresivni oblik. Prikaz bolesnika. U radu je prikazana bolesnica stara 35 godina sa NHL, DLBCL, lokalizovanim u grliću materice, kojoj je nakon biopsije grlića materice, patohistološki dijagnostikovana displazija lakog stepena (CIN1/L-SIL) pokrovnog epitela grlića materice, a zatim dokazana infekcija humanim papiloma virusom (HPV), podtipovima 16 i 31. Dijagnoza DLBCL je patohistološki potvrđena na koničnom isečku vaginalne porcije uterusa, nakon čega je bolesnica lečena sa osam ciklusa hemioterapije po protokolu RCHOP. Zaključak. Koegzistencija CIN1/L-SIL i NHL je slučajna. Usled toga, može se prevideti prateći cervikalni limfom, koji je uobičajeno lokalizovan subepitelno, ukoliko se biopsije ne uzimaju na adekvatan način i ukoliko se ne uradi HPV serotipizacija uzorka biopsije.

Reference

1.      Korcum AF, Karadogan I, Aksu G, Aralasmak A, Erdogan G. Primary follicular lymphoma of the cervix uteri: a review. Ann Hematol 2007; 86(9): 623‒30.

2.      Carbone PP, Kaplan HS, Musshoff K, Smithers DW, Tubiana M. Report of the Committee on Hodgkin's Disease Staging Classification. Cancer Res 1971; 31(11): 1860‒ 1.

3.      Matasar MJ, Zelenetz AD. Overview of lymphoma diagnosis and management. Radiol Clin North Am 2008; 46(2): 175‒98, vii.

4.      Miranda-Filho A, Piñeros M, Znaor A, Marcos-Gragera R, Steliarova-Foucher E, Bray F. Global patterns and trends in the incidence of non-Hodgkin lymphoma. Cancer Causes Control 2019; 30(5): 489‒99.

5.      Del M, Angeles MA, Syrykh C, Martínez-Gómez C, Martínez A, Ferron G, et al. Primary B-Cell lymphoma of the uterine cervix presenting with right ureter hydronephrosis: A case report. Gynecol Oncol Rep 2020; 34: 100639.

6.      Wang J, Zeng L, Chen S, Wu Q, Ma L, Wu S, et al. Lymphoma of the female genital tract: a clinicopathological analysis of 25 cases. Am J Transl Res 2019; 11(9): 5800‒11.

7.      De Greve T, Vanwalleghem L, Van Hoof A, Coenegrachts K, Van Trappen P. An unusual cervical tumor as presentation of a non-hodgkin lymphoma. Case Rep Obstet Gynecol 2014; 2014: 549619.

8.      Selvi Demirtas G, Gokcu M, Sancı M, Ekmekci S, Yıldız HI. Primary non-Hodgkin's lymphoma masquerading as cervical cancer. Ginekol Pol 2020; 91(9): 571.

9.      Pratap S, Scordino TS. Molecular and cellular genetics of non-Hodgkin lymphoma: Diagnostic and prognostic implications. Exp Mol Pathol 2019; 106: 44‒51.

10.   Roman E, Smith AG. Epidemiology of lymphomas. Histopathology 2011; 58(1): 4‒14.

11.   Intaraphet S, Farkas DK, Johannesdottir Schmidt SA, Cronin-Fenton D, Søgaard M. Human papillomavirus infection and lymphoma incidence using cervical conization as a surrogate marker: a Danish nationwide cohort study. Hematol Oncol 2017; 35(2): 172‒6.

12. Fontham ETH, Wolf AMD, Church TR, Etzioni R, Flowers CR, Herzig A, et al. Cervical cancer screening for individuals at average risk: 2020 guideline update from the American Cancer Society. CA Cancer J Clin 2020; 70(5): 321‒46.

Objavljeno
2023/01/04
Rubrika
Prikaz bolesnika